Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 56.22% vs 145.15% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 42.21% vs 152.04% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 24.37% vs 5.92% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 58.47% vs 130.10% in Mar 2024
Compare Profit and Loss Results of Asston Pharmaceu
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
25.00
74.00
-49.00
-66.22%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
25.00
74.00
-49.00
-66.22%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
6.00
-6.00
-100.00%
Raw Materials Consumed
14.00
63.00
-49.00
-77.78%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
1.00
5.00
-4.00
-80.00%
Operating Expenses
0.00
8.00
-8.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
1.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
91.00
-72.00
-79.12%
Operating Profit (PBDIT) excl Other Income
5.00
-16.00
21.00
131.25%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
6.00
-14.00
20.00
142.86%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
5.00
-18.00
23.00
127.78%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
5.00
-20.00
25.00
125.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
-20.00
25.00
125.00%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
3.00
-20.00
23.00
115.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3.00
14.00
-11.00
-78.57%
Profit Available for appropriations
7.00
-5.00
12.00
240.00%
Appropriations
7.00
-5.00
12.00
240.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.14
-21.9
28.04
128.04%
Profit And Loss - Net Sales
Net Sales 25.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 56.22% vs 145.15% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.21% vs 152.04% in Mar 2024
Profit And Loss - Interest
Interest 0.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.37% vs 5.92% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 3.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 58.47% vs 130.10% in Mar 2024
